Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 2/20 | 0.45 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | TERT | O14746 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 3/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.39 |
| ▸ | PPARD | Q03181 | 2/20 | 0.39 |
| ▸ | PPARA | Q07869 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | FABP4 | P15090 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27191621 | 0.95 | TBXAS1 (0.50) | TBXAS1TRPV1FAAHTERT | |
| SCHEMBL18262818 | 0.95 | TBXAS1 (0.50) | TBXAS1TRPV1FAAHTERT | |
| SCHEMBL18262817 | 0.95 | TBXAS1 (0.50) | TBXAS1TRPV1FAAHTERT | |
| SCHEMBL89096 | 0.87 | TBXAS1 (0.56) | TBXAS1TERTALDH1A1CYP3A4CYP19A1 | |
| SCHEMBL18019076 | 0.86 | TBXAS1 (0.43) | TBXAS1TERTPPARGFFAR1PPARD | |
| SCHEMBL23071637 | 0.85 | TBXAS1 (0.59) | TBXAS1TERTALDH1A1CYP3A4CYP19A1 | |
| SCHEMBL3497513 | 0.85 | TBXAS1 (0.59) | TBXAS1TERTALDH1A1CYP3A4CYP19A1 | |
| SCHEMBL2775177 | 0.85 | TBXAS1 (0.59) | TBXAS1TERTALDH1A1CYP3A4CYP19A1 | |
| SCHEMBL11277600 | 0.85 | TBXAS1 (0.59) | TBXAS1TERTALDH1A1CYP3A4CYP19A1 | |
| SCHEMBL535710 | 0.85 | TBXAS1 (0.59) | TBXAS1TERTALDH1A1CYP3A4CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130302247-A1 | SYNTHESIS OF FLUOROARACHIDONIC ACID AND METHODS OF USE THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2013-11-14 | — | — | US | disclosed |
| US-20090036410-A1 | Structured Phospholipids | BTG INTERNATIONAL LIMITED (GB) | 2009-02-05 | — | — | US | disclosed |
| EP-1885377-A2 | STRUCTURED PHOSPHOLIPIDS FOR TREATING AUTOIMMUNE AND NEURODEGENERATIVE DISEASES | BTG INTERNATIONAL LIMITED (GB) | 2008-02-13 | — | — | EP | disclosed |
| WO-2006056783-A2 | STRUCTURED PHOSPHOLIPIDS FOR TREATING AUTOIMMUNE AND NEURODEGENERATIVE DISEASES | BTG INTERNATIONAL LIMITED (GB) | 2006-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036410-A1 | Structured Phospholipids | SGMS1, SGMS2, SMPD1 | TBXAS1 575/4885TRPV1 4536/4885FAAH 92/4885 |
| US-20130302247-A1 | SYNTHESIS OF FLUOROARACHIDONIC ACID AND METHODS OF USE THEREOF | ALOX15B, ALOX15, ALOX5 | TBXAS1 96/4885TRPV1 2708/4885FAAH 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.